Biotechnology
Venture Capital
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Investor profile
Venture capitalInvestments
1
1 of them startups
Hiring now
1
5 open roles
Focusshare of its companies
Cell & Gene Therapy 100%Immunology & Inflammation Therapeutics 100%
Stage of its companies
Series A 100%
Sources: 1 rounds in the press that name it
Overview
The Column Group is a science-driven venture capital firm dedicated to fueling scientific innovation in the life sciences. It creates and funds early-stage drug discovery companies built around fundamental biological insights, with a partnership made up largely of accomplished scientists. The firm was founded in San Francisco in 2007 by David Goeddel and Peter Svennilson, and its early portfolio includes NGM Biopharmaceuticals.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
50-200 est. staff
